Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 21, 2007, Pages 6632-6641

  Karki, Subhas S ^a   Thota, Sreekanth ^a   Darj, Satyanarayana Y ^a   Balzarini, Jan ^b   De Clercq, Erik ^b  

^a A Constituent Unit of KLE Academy of Higher Education Research   (India)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Anticancer; Cytotoxicity; Ruthenium compounds; Thiosemicarbazones

Indexed keywords

ANTINEOPLASTIC AGENT; BIS(1,10 PHENANTHROLINE) 1 (2' CHLOROBENZYL)THIOSEMICARBAZONE RUTHENIUM CHLORIDE; BIS(1,10 PHENANTHROLINE) 1 (2'FLUOROBENZYL)THIOSEMICARBAZONE RUTHENIUM CHLORIDE; BIS(1,10 PHENANTHROLINE) 1 (4' CHLOROBENZYL)THIOSEMICARBAZONE RUTHENIUM CHLORIDE; BIS(1,10 PHENANTHROLINE) 1,4 METHOXY BENZYLTHIOSEMICARBAZONE RUTHENIUM CHLORIDE; BIS(1,10 PHENANTHROLINE) 2 [(3 CHLORO 4 FLUOROPHENYLAMINO)METHYL]PHENOL RUTHENIUM CHLORIDE; BIS(1,10 PHENANTHROLINE)ISATIN 3 THIOSEMICARBAZONE RUTHENIUM CHLORIDE; BIS(2,2 BIPYRIDINE) 1 (2' CHLOROBENZYL)THIOSEMICARBAZONE RUTHENIUM CHLORIDE; BIS(2,2 BIPYRIDINE) 1 (2'FLUOROBENZYL)THIOSEMICARBAZONE RUTHENIUM CHLORIDE; BIS(2,2 BIPYRIDINE) 1 (4' CHLOROBENZYL)THIOSEMICARBAZONE RUTHENIUM CHLORIDE; BIS(2,2 BIPYRIDINE) 1,4 METHOXY BENZYLTHIOSEMICARBAZONE RUTHENIUM CHLORIDE; BIS(2,2 BIPYRIDINE) 2 [(3 CHLORO 4 FLUOROPHENYLAMINO)METHYL]PHENOL RUTHENIUM CHLORIDE; BIS(2,2 BIPYRIDINE)ISATIN 3 THIOSEMICARBAZONE RUTHENIUM CHLORIDE; CISPLATIN; RUTHENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARBON NUCLEAR MAGNETIC RESONANCE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR; IC 50; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; HUMANS; LIGANDS; MICE; MICE, INBRED STRAINS; ORGANOMETALLIC COMPOUNDS; RUTHENIUM; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MURINAE; MUS;

EID: 34548564541     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.08.014     Document Type: Article

References (50)

1. Galanski M., Arion V.B., Jakupec M.A., and Keppler B.K. Curr. Pharm. Des. 9 (2003) 2078-2089
2. Jakupec M.A., Galanski M., and Keppler B.K. Rev. Physiol. Biochem. Pharmacol. 146 (2003) 1-53
3. Galanski M., Jakupec M.A., and Keppler B.K. Curr. Med. Chem. 12 (2005) 2075-2094
4. Clarke M.J. Coord. Chem. Rev. 236 (2003) 209-233
5. Clarke M.J., Zhu F., and Frasca D.R. Chem. Rev. 99 (1999) 2511-2534
6. Jakupec M.A., and Keppler B.K. In: Sigel A., and Sigel H. (Eds). Metal Ions in Biological Systems 42 (2004), Dekker, New York 425-462
7. Guo Z., and Sadler P.J. Angew. Chem., Int. Ed. Engl. 38 (1999) 1512-1531
8. Clarke M.J. In: Sigel H., and Sigel A. (Eds). Metal Ions in Biological Systems 11 (1980), Marcel Dekker, New York 231-283
9. Rudolph R. Arch. Exp. Veterinarmed. 25 (1971) 925-935
10. Anghileri L.J., and Krebsforsch Z. Klin. Onkol. Cancer Res. Clin. Oncol. 83 (1975) 213-217
11. Keppler B.K., Henn ., Juhl U.M., Berger M.R., Niebi R., and Wagner F.E. Prog. Clin. Biochem. Med. 10 (1989) 41-69
12. Novakova O., Kasparkova J., Vrana O., Van Vliet P.M., Reedijk J., and Brabec V. Biochemistry 34 (1995) 12369-12378
13. Vilaplana R.A., Gonzalez-Vichez F., Gutierrez-Puebla E., and Ruiz-Valero C. Inorg. Chim. Acta 224 (1994) 15-18
14. Sava G., Bergamo A., Zorzet S., Gava B., Casarsa C., Cocchietto M., Furlani A., Scarcia V., Serli B., Iengo E., Alessio E., and Mestroni G. Eur. J. Cancer 38 (2002) 427-435
15. Keppler B.K., Wehe D., Endres H., and Rupp W. Inorg. Chem. 26 (1987) 844-896
16. Keppler B.K., Rupp W., Juhl U.M., Endres H., Nieu R., and Balzer W.S. Inorg. Chem. 26 (1987) 4366-4370
17. Sava G., Gangliardi R., Bergamo A., Alessio E., and Mestroni G. Anticancer Res. 19 (1999) 969-972
18. Velders A.H., Pazderski L., Ugozzoli F., Biagini-Cingi M., Manotti-Lanfredi A.M., Haasnoot J.G., and Reedijk J. Inorg. Chim. Acta 273 (1998) 259-265
19. Velders A.H., Ugozzoli F., Biagini-Cingi M., Manotti-Lanfredi A.M., Haasnoot J.G., and Reedijk J. Eur. J. Inorg. Chem. (1999) 213-215
20. Sava G., and Bergamo A. Int. J. Oncol. 17 (2000) 353-365
21. Rademaker-Lakhai J.M., Bongard D.V., Pluim D., Beijnen J.H., and Schellens J.H. Clin. Cancer Res. 10 (2004) 3717-3727
22. Gagliardi R., Sava G., Pacor S., Mestroni G., and Alessio E. Clin. Exp. Metastasis 12 (1994) 93-100
23. Magnarin M., Bergamo A., Carotenuto M.E., Zorzet S., and Sava G. Anticancer Res. 20 (2000) 2939-2944
24. Cocchietto M., and Sava G. Pharmacol. Toxicol. 87 (2000) 193-197
25. Zorzet S., Sorc A., Casarsa C., Cocchietto M., and Sava G. Met.-Based Drugs 8 (2001) 1-7
26. Sava G., Clerici K., Capozzi I., Cocchietto M., Gagliardi R., Alessio E., and Mestroni G. Anticancer Drugs 10 (1999) 129-138
27. Sava G., Gagliardi R., Cocchietto M., Clerici K., Capozzi I., Marella M., Alessio E., Mestroni G., and Milanino R. Pathol. Oncol. Res. 4 (1998) 30-36
28. Keppler B.K., Henn M., Juhl U.M., Berger M.R., Niebl R., and Wagner F.E. Prog. Clin. Biochem. Med. 10 (1989) 41-69
29. Kreuser E.D., Keppler B.K., Berdel W.E., Piest A., and Thiel E. Semin. Oncol. 19 (1992) 73-81
30. Srivastava S.C., Richard P., Meinken G.E., Larson S.M., and Grunbaum Z. Tumor Uptake of Radioruthenium Compounds. In: Spencer R.P. (Ed). Radiopharmaceuticals-Structure-Activity Relationships (1981), Grune & Stratton Inc., New York 207-223
31. Sava G., Pacor S., Zorzet S., Alessio E., and Mestroni G. Pharmacol. Res. 21 (1989) 617-628
32. Zorzet S., Bergamo A., Cocchietto M., Sorc A., Gava B., Alessio E., Iengo E., and Sava G. J. Pharmacol. Exp. Ther. 295 (2000) 927-933
33. Clarke M.J., Galang R.D., Rodriguez V.M., Kumar R., Pell S., and Bryan D.M. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy (1988), Nijhoff, Boston, MA 582
34. Tysoe S.A., Morgan R.J., Baker D., and Strekas T.C. J. Phys. Chem. 97 (1993) 1707-1711
35. Clairs S.A., and Paul J.D. Platinum Metals Rev. 45 (2001) 62-69
36. Mazumder U.K., Gupta M., Bera A., Bhattacharya S., Karki S., Manikandan L., and Patra S. Indian J. Chem. 42 A (2003) 313-317
37. Mazumder U.K., Gupta M., Karki S.S., Bhattacharya S., Suresh R., and Sivakumar T. J. Enzyme Inhib. Med. Chem. 19 (2004) 185-192
38. Chem. Pharm. Bull. 52 (2004) 178-185
39. Bioorg. Med. Chem. 13 (2005) 5766-5773
40. Suresh R., Karki S.S., Bhattacharya S., Manikandan L., Prabhakaran S.G., Mazumder U.K., and Gupta M. J. Enzyme Inhib. Med. Chem. 21 (2006) 501-507
41. Sah P.P.T., and Daniel T.C. Rev. Trav. Chim. 69 (1950) 1545
42. Bakkar M.S., Siddiqi M.Y., and Monshi M.S. Synth. React. Inorg. Met.-Org. Chem. 33 (2003) 1157-1169
43. Yupeng T., Chunying D., Cunyuan Z., Xiao-zeng You T.C., Mak W., and Zeying Z. Inorg. Chem. 36 (1997) 1247-1252
44. Chitra S., and Singh R.V. Appl. Organomet. Chem. 9 (1995) 675-681
45. Bernstein J., Yale H.L., Losee K., Holsing M., Martins J., and Lott W.A. J. Am. Chem. Soc. 73 (1951) 906-912
46. Giordano P.J., Bock C.R., and Wrighton M.S. J. Am. Chem. Soc. 100 (1978) 6960-6966
47. Nardelli M., Gasparri G.F., Battislini G.G., and Musatti A. Chem. Commun. (1965) 187-188
48. Gasparri G.F., Mangia A., Musatti A., and Nardelli M. Acta Crystallogr., Sect. B. 24 (1968) 367-374
49. Litchfield J.T., and Wilcoxon F. J. Pharmacol. Exp. Ther. 96 (1958) 99-113
50. Balzarini J., De Clercq E., Mertes M.P., Shugar D., and Torrence P.F. Biochem. Pharmacol. 31 (1982) 3673-3682